• Mashup Score: 0

    Brief communication Genetic load in incomplete lupus erythematosus (4 January, 2023) , Joseph M Kheir, Miles Smith, Colin Mowery, Susan Macwana, Wade DeJager, Catriona A Wagner, Teresa Aberle, Judith A James, Joel M Guthridge Epidemiology and outcomes Original research: A better self-efficacy is predictive of better health-related quality of life…

    Tweet Tweets with this article
    • Latest content at #Lupus #Science and #Medicine #SLE #Autoimmunity #Rheumatology #ChronicDisease #Nephritis #Treatment #Biomarkers https://t.co/rvSwWGtRLq

  • Mashup Score: 0

    Patient-reported outcome measures (PROMs) are useful tools for informing clinicians about the impact of disease on patients and are increasingly used as endpoints in clinical trials. The Skindex-29+3 is a dermatologic PROM that builds on the previously validated Skindex-29 with three additional cutaneous lupus erythematosus (CLE)-specific questions on hair loss and photosensitivity.1 The…

    Tweet Tweets with this article
    • This week on LSM: @werthlab Comparing #dermatologic #patient-reported #outcome measures in #cutaneous #lupus erythematosus #cutaneouslupus #SLE https://t.co/3tytWVKive

  • Mashup Score: 0

    Patient-reported outcome measures (PROMs) are useful tools for informing clinicians about the impact of disease on patients and are increasingly used as endpoints in clinical trials. The Skindex-29+3 is a dermatologic PROM that builds on the previously validated Skindex-29 with three additional cutaneous lupus erythematosus (CLE)-specific questions on hair loss and photosensitivity.1 The…

    Tweet Tweets with this article
    • This week on LSM: @werthlab Comparing #dermatologic #patient-reported #outcome measures in #cutaneous #lupus erythematosus #cutaneouslupus #SLE https://t.co/3tytWVKive

  • Mashup Score: 0

    Patient-reported outcome measures (PROMs) are useful tools for informing clinicians about the impact of disease on patients and are increasingly used as endpoints in clinical trials. The Skindex-29+3 is a dermatologic PROM that builds on the previously validated Skindex-29 with three additional cutaneous lupus erythematosus (CLE)-specific questions on hair loss and photosensitivity.1 The…

    Tweet Tweets with this article
    • This week on LSM: @werthlab Comparing #dermatologic #patient-reported #outcome measures in #cutaneous #lupus erythematosus #cutaneouslupus #SLE https://t.co/3tytWVKive